-transparent.png){kind=logo}
The objective of the present work was to evaluate on the basis of the authors' data and data in the literature the role of phospholipase A2 in the pathogenesis of schizophrenia. The authors submit available literature pertaining to the problem as well as their own experimental findings. Based on the submitted facts, it cannot be states that phospholipase A2 is a specific marker of schizophrenia.
Related Publications
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
January 1992,
Biological psychiatry,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
August 1999,
The British journal of psychiatry : the journal of mental science,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
August 1998,
Archives of general psychiatry,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
July 1995,
Schizophrenia research,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
March 2019,
Psychiatry research,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
August 1996,
Prostaglandins, leukotrienes, and essential fatty acids,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
August 2004,
Biological & pharmaceutical bulletin,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
September 1990,
Biological psychiatry,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
April 1990,
Fortschritte der Neurologie-Psychiatrie,
D Rípová, and
I Farská, and
V Nĕmcová, and
H Papezová
September 2004,
Psychiatric genetics,
